Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Calvino

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Anticancer Research|July 1, 1989
Cytotoxic activity of aryl and heteroaroxylazoxy derivativesR Fruttero, R Calvino, P Aresca, et al.
Journal of Medicinal Chemistry|August 21, 1992
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregationR Calvino, R Fruttero, D Ghigo, et al.
Heart (British Cardiac Society)|June 1, 1997
Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X)P M Elliott, K Krzyzowska-Dickinson, R Calvino, et al.
Die Pharmazie|July 1, 1988
In vitro cytotoxic activity of aryl and heteroaryl-ONN-azoxycyanidesR Fruttero, R Calvino, A Di Stilo, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1993
Pharmacochemistry of the furoxan ring: recent developmentsR Calvino, A Di Stilo, R Fruttero, et al.
Biochemical Pharmacology|March 17, 1992
Characterization of a new compound, S35b, as a guanylate cyclase activator in human plateletsD Ghigo, R Heller, R Calvino, et al.
Heart (British Cardiac Society)|November 16, 2006
Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extractionM K Sinha, J M Vazquez, R Calvino, et al.
Pharmacological Research|October 1, 1993
No-mimetic furoxans: arylsulphonylfuroxans and related compoundsR Ferioli, A Fazzini, G C Folco, et al.
Agents and Actions. Supplements|January 1, 1995
Activation of endothelial guanylate cyclase inhibits cellular reactivityR Heller, F Bussolino, D Ghigo, et al.
The American Journal of Cardiology|April 15, 1996
Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectorisJ C Kasi, Y Zhang, R Calvino, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Anticancer Research|July 1, 1989
Cytotoxic activity of aryl and heteroaroxylazoxy derivativesR Fruttero, R Calvino, P Aresca, et al.
Journal of Medicinal Chemistry|August 21, 1992
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregationR Calvino, R Fruttero, D Ghigo, et al.
Heart (British Cardiac Society)|June 1, 1997
Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X)P M Elliott, K Krzyzowska-Dickinson, R Calvino, et al.
Die Pharmazie|July 1, 1988
In vitro cytotoxic activity of aryl and heteroaryl-ONN-azoxycyanidesR Fruttero, R Calvino, A Di Stilo, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1993
Pharmacochemistry of the furoxan ring: recent developmentsR Calvino, A Di Stilo, R Fruttero, et al.
Biochemical Pharmacology|March 17, 1992
Characterization of a new compound, S35b, as a guanylate cyclase activator in human plateletsD Ghigo, R Heller, R Calvino, et al.
Heart (British Cardiac Society)|November 16, 2006
Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extractionM K Sinha, J M Vazquez, R Calvino, et al.
Pharmacological Research|October 1, 1993
No-mimetic furoxans: arylsulphonylfuroxans and related compoundsR Ferioli, A Fazzini, G C Folco, et al.
Agents and Actions. Supplements|January 1, 1995
Activation of endothelial guanylate cyclase inhibits cellular reactivityR Heller, F Bussolino, D Ghigo, et al.
The American Journal of Cardiology|April 15, 1996
Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectorisJ C Kasi, Y Zhang, R Calvino, et al.
Pageof 3